Health Catalyst, Inc. (HCAT) Earnings History
Net Loss9 years of earnings data (2017–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Health Catalyst, Inc. (HCAT) Earnings Overview
As of July 7, 2026, Health Catalyst, Inc. (HCAT) reported trailing twelve-month net income of -$265M, reflecting -121.7% year-over-year growth. The company earned $-3.65 per diluted share over the past four quarters, with a net profit margin of -57.2%.
Looking at the long-term picture, HCAT's historical earnings data spans multiple years. The company achieved its highest annual net income of -$47M in fiscal 2017.
Health Catalyst, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including HIMS (-$13M net income, 5.5% margin), DOCS ($196M net income, 30.4% margin), INVA ($504M net income, 63.8% margin), HCAT has room to improve margins relative to the peer group. Compare HCAT vs HIMS →
HCAT Earnings vs Peers
Earnings metrics vs comparable public companies
HCAT Historical Earnings Data (2017–2025)
9 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$178M | -156.1% | -$36M | $-2.55 | -57.2% | -11.6% |
| 2024 | -$70M | +41.2% | -$70M | $-1.15 | -22.7% | -22.8% |
| 2023 | -$118M | +14.0% | -$127M | $-2.09 | -39.9% | -42.9% |
| 2022 | -$137M | +10.3% | -$140M | $-2.54 | -49.7% | -50.7% |
| 2021 | -$153M | -33.2% | -$144M | $-3.23 | -63.3% | -59.4% |
| 2020 | -$115M | -91.4% | -$96M | $-2.91 | -60.9% | -50.9% |
| 2019 | -$60M | +3.0% | -$55M | $-3.21 | -38.8% | -35.4% |
| 2018 | -$62M | -31.8% | -$60M | $-2.23 | -55.1% | -53.4% |
| 2017 | -$47M | - | -$46M | $-1.69 | -64.4% | -62.3% |
Download Data
Export HCAT earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
9+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
HCAT — Frequently Asked Questions
Quick answers to the most common questions about buying HCAT stock.
What is HCAT earnings per share (EPS)?
HCAT trailing twelve-month (TTM) diluted EPS is $-3.65, reflecting -121.7% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2017 to 2025 is available in the table on this page.
What is Health Catalyst, Inc.'s net income?
Health Catalyst, Inc. (HCAT) trailing twelve-month net income is $-265M as of 2025. Earnings declined -121.7% year-over-year.
Is HCAT profitable?
HCAT is not currently profitable on a TTM basis, reporting a net loss of $-265M. Net margin is -57.2%. Investors should monitor for a return to profitability.
What is HCAT's earnings growth rate?
HCAT compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2017 to 2025.
What are HCAT's profit margins?
Health Catalyst, Inc. net profit margin is -57.2%, operating margin is -11.6%, and gross margin is +33.5%. Below-average margins reflect competitive or cost pressures. Return on Equity is -58.3%.
Is HCAT growing earnings?
HCAT earnings are declining — EPS fell -121.7% year-over-year. TTM net income dropped to $-265M. This contrasts with the 5-year CAGR of N/A.
What was HCAT's best earnings year?
Health Catalyst, Inc.'s highest annual net income on record is $-47M, achieved in fiscal year 2017. Earnings history on this page spans 2017 to 2025 and includes all annual and quarterly figures.
What were HCAT's earnings last quarter?
HCAT's most recent reported quarter was Q1 2026. Net income was $-111M with diluted EPS of $-1.53. For a full breakdown of all quarters, see the quarterly earnings table on this page.